Literature DB >> 6444819

Suppressor cell loss and dysfunction in mixed connective tissue disease.

D Alarcón-Segovia, A Ruíz-Arguelles.   

Abstract

Of 11 patients with untreated mixed connective tissue disease (MCTD) who were studied, all had decreased circulating T gamma cells, and all but one had decreased suppressor cell function of T cells on B cells, determined by a reverse hemolytic plaque-cell assay. Results in 21 normal subjects were significantly, different. Incubation of mononuclear cells from MCTD patients in purified anti-ribonucleoprotein (anti-RNP) IgG resulted in further decrease in their suppressor function. Decrease of T gamma cells and their suppressor function may be due to in vivo penetration of anti-RNP antibody into T gamma cells, causing their deletion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444819     DOI: 10.1002/art.1780230308

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

1.  Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease.

Authors:  H Becker; A Langrock; K Federlin
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Mixed connective tissue disease. A clinico-serological study of 17 cases.

Authors:  I García-de la Torre; M Salazar-Páramo; G Salmón-de la Torre
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

3.  Cellular regulation of anti-nRNP antibody synthesis is different from that of anti-DNA antibody synthesis in patients with systemic lupus erythematosus.

Authors:  O Hosono; T Takeuchi; J Koide; M Takano; T Abe
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

4.  Human post-thymic precursor cells in health and disease. IX. Immunoregulatory T cell circuits in peripheral blood of patients with rheumatoid arthritis.

Authors:  R Palacios; A Ruíz-Arguelles; D Alarcón-Segovia
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

5.  Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases.

Authors:  J Alcocer-Varela; A Laffón; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Remission of scleroderma during chemotherapy for lymphoma.

Authors:  M Comer; A R Harvey
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.